• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: EDWARDS LIFESCIENCES CARPENTIER-EDWARDS PHYSIO II ANNULOPLASTY; RING, ANNULOPLASTY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

EDWARDS LIFESCIENCES CARPENTIER-EDWARDS PHYSIO II ANNULOPLASTY; RING, ANNULOPLASTY Back to Search Results
Model Number 5200
Device Problem Appropriate Term/Code Not Available (3191)
Patient Problems Mitral Regurgitation (1964); Organ Dehiscence (2502)
Event Date 08/06/2019
Event Type  Injury  
Manufacturer Narrative
(b)(4).The device was returned to edwards for evaluation.Evaluation is in progress.The device history record (dhr) was reviewed and shows that this device met all manufacturing specifications for product release prior to distribution.No issues were identified that would have impacted this event.Ring dehiscence may occur early or late.When it occurs in the early post-operative period, it is typically a result of an inadequate valve repair in combination with friable myocardial tissue.Late dehiscence can occur as a result of successive dilatation of cardiac structures that result from progression of disease or from endocarditis.A manufacturing related issue was not identified.A definitive root cause could not be determined.Edwards lifesciences will continue to monitor all reported events.No further actions are required at this time.
 
Event Description
It was reported via the implant patient registry that a 34mm mitral ring, implanted approximately for one (1) year and 10 months, was explanted due to dehiscent mitral ring with severe mitral regurgitation.The explanted device was replaced with a 29mm bioprosthetic valve.The patient developed a post op coagulopathy requiring blood clots.The patient became hemodynamically unstable immediately following the pump run and an intra-aortic balloon pump had to be placed.The patient returned to the icu in critical, but satisfactory condition.
 
Manufacturer Narrative
Device evaluation: customer report of dehiscence and regurgitation could not be confirmed through visual observations.As received, the ring exhibited minimal host tissue overgrowth and x-ray demonstrated ring intact.The sewing cloth had straight and even cuts at multiple locations around the ring; silicone cuts were observed underneath two of the three sewing cloth cuts.Sutures remained attached on the sewing ring.Multiple pieces of native tissues and suture threads were also returned along with device.
 
Manufacturer Narrative
Corrected data: f10, h6.Reference capa-20-00141.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CARPENTIER-EDWARDS PHYSIO II ANNULOPLASTY
Type of Device
RING, ANNULOPLASTY
Manufacturer (Section D)
EDWARDS LIFESCIENCES
1 edwards way
irvine CA 92614
MDR Report Key9071385
MDR Text Key161415693
Report Number2015691-2019-03449
Device Sequence Number1
Product Code KRH
Combination Product (y/n)N
PMA/PMN Number
K083470
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional,other
Type of Report Initial,Followup,Followup
Report Date 08/22/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/16/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date02/15/2021
Device Model Number5200
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer09/09/2019
Date Manufacturer Received07/23/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age81 YR
-
-